Abstract
Summary
Lysergic acid diethylamide (LSD) was administered to guinea pigs that had received subcutaneous injections of brain homogenate. Dosages of 20 or 50 μg/kg triweekly reduced the incidence of paralysis as well as mortality rate. In animals that had demonstrable histopathologic lesions after the drug, the severity of the lesions was reduced.
Get full access to this article
View all access options for this article.